Missing/wrong data?
Log in to edit
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia
scientific article
Author/s
author: Stephen A. Strickland, Farhad Ravandi, Gautam Borthakur, Richard D Leavitt, Wendy Stock, Larry D. Cripe, Paul J Shami
Work details
Publication date
November 17, 2014
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.